Completed PHASE2 INTERVENTIONAL 1-arm NCT04068207

Minocycline Treatment in Retinitis Pigmentosa

The Efficacy and Safety of Oral Minocycline in the Treatment of Retinitis Pigmentosa: An Open-label Clinical Trial

Sponsor: Sun Yat-sen University

Conditions Inherited Retinal Dystrophy Retina Disorder Retinitis Pigmentosa

Interventions Minocycline

Updated 9 times since 2019 Last updated: Dec 19, 2023 Started: Aug 25, 2019 Primary completion: Jan 31, 2023 Completion: Dec 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Inherited Retinal Dystrophy and Retina Disorder and is currently completed. Sun Yat-sen University leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2024 — Jul 2024 [monthly]

Completed PHASE2

Status: Recruiting → Completed
May 2023 — Jan 2024 [monthly]

Recruiting PHASE2
Oct 2021 — May 2023 [monthly]

Recruiting PHASE2

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE2
Mar 2020 — Jan 2021 [monthly]

Recruiting PHASE2
Oct 2019 — Mar 2020 [monthly]

Recruiting PHASE2
Sep 2019 — Oct 2019 [monthly]

Recruiting PHASE2

First recorded

Aug 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-sen University

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China